A 6-week, multicentre, prospective, open-label, observational study to evaluate the efficacy of tadalafil in men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction

Trial Profile

A 6-week, multicentre, prospective, open-label, observational study to evaluate the efficacy of tadalafil in men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2015

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Benign prostatic hyperplasia; Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms TadaLutsEd
  • Most Recent Events

    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top